|
|

|
|
Sponsored by:
|
|
|
Monday, 19 February
Tuesday, 20 February
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 9.00-9.30 |
|
WELCOMING REMARKS & INTRODUCTIONS |
John Faber, International Centre for Diffraction Data, Newtown Square, Pennsylvania, USA |
| |
XRPD Structural Techniques (Acquisition and Use of XRPD Data, Indexing, Structure Determination, Rietveld Refinement)
Session Chair: A. Kern, Bruker AXS GmbH, Karlsruhe, Germany
|
| 9.30-10.30 |
Invited |
QUANTITATIVE PHASE ANALYSIS OF PHARMACEUTICAL COMPOUNDS BY THE WHOLE-PATTERN DECOMPOSITION METHODS
|
Didier Clénet, Sanofi-Aventis, Vitry-sur-Seine, France |
| 10.30-11.00 |
Contributed |
DO 'STANDARD' DIRECT METHODS STILL HAVE A ROLE TO PLAY IN XRPD STRUCTURE DETERMINATION OF MOLECULAR SOLIDS?
|
Kenneth Shankland, CCLRC, Rutherford Appleton Lab, Chilton, Oxon, UK |
| 11.00-11.30 |
Break |
|
|
| 11.30-12.00 |
Contributed |
RE-EXAMINING STRUCTURE AND CRYSTALLINITY IN CELLULOSE
|
Timothy Fawcett, International Centre for Diffraction Data, Newtown Square, PA, USA |
| 12.00-12.30 |
Contributed |
STRUCTURE ANALYSIS FROM POWDER DIFFRACTION DATA SUPPORTED BY TOTAL ENERGY CALCULATIONS
|
Max Petersen, Accelrys, Inc., San Diego, CA, USA |
| |
Powder Diffraction Using Synchrotron Sources for Pharmaceutical Problems
Chair: P. Stephens, Stony Brook University, Stony Brook, NY, USA |
| 12.30-13.30 |
Invited |
POWDER DIFFRACTION USING SYNCHROTRON SOURCES FOR PHARMACEUTICAL PROBLEMS
|
Peter Stephens, Stony Brook University, Stony Brook, NY, USA |
| 13.30-15.00 |
Lunch |
|
|
| Afternoon |
Complementary Techniques Session Chair: R. Suryanarayanan, University of Minnesota, College of Pharmacy, Minneapolis, MN, USA |
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 15.00-16.00 |
Invited |
COMBINED XRD AND RAMAN COMBINATORIAL SCREENING
|
Arnt Kern, Bruker AXS, Karlsruhe, Germany |
| 16.00-16.30 |
Break |
|
|
| 16.30-17.00 |
Contributed |
X-RAY DIFFRACTION AND COMPLEMENTARY ANALYTICAL TECHNIQUES INCLUDING MICROSCOPY, RAMAN, AND SMALL ANGLE X-RAY SCATTERING
|
Linda Sauer, University of Minnesota, Minneapolis, MN, USA |
| 17.00-17.30 |
Contributed |
HOW TO COMBINE PXRD, RAMAN AND OTHER 1-D DATA IN HIGH THROUGHPUT POLYMORPH/SALT/CO-CRYSTAL STUDIES
|
Christopher Gilmore, University of Glasgow, Glasgow, Scotland, UK |
| Evening (18.30-21.00)
Poster Session |
| Title of Paper |
Speaker & Affiliation |
| USAGE OF AN ADVANCED FULLPAT METHOD TO QUANTIFY AMORPHOUS MATERIAL
|
Detlef Beckers, PANalytical, Almelo, The Netherlands |
| WHEN KEEN OBSERVATION SAVES YOU MONEY
|
Zvicka Deutsch, Ben Gurion University of the Negev, Be'er Sheva, Israel |
| VALIDATING CRYSTAL STRUCTURES SOLVED FROM POWDER DIFFRACTION DATA USING THE dSNAP SOFTWARE
|
Christopher Gilmore, University of Glasgow, Glasgow, Scotland, UK |
| POWDER X-RAY DIFFRACTION IN THE RANGE 2 THETA < 15° (lambda = 0.154nm)
|
Thomas Holz, AXO DRESDEN GmbH, Heidenau, Germany |
| XRPD FOR NONDESTRUCTIVE CHARACTERIZATION OF SOLID DOSAGE FORMS
|
Vladimir Kogan, DANNALAB & PANalytical, Almelo, The Netherlands |
| X-RAY POWDER DIFFRACTION PATTERN OF IMIPENEM MONOHYDRATE
|
Fangling Needham, International Centre for Diffraction Data, Newtown Square, PA, USA |
| SOLID STATE CHARACTERIZATION OF A POTENTIALLY ACTIVE BENZOTHIAZOL DERIVATIVE
|
Marco Pallagrosi, Industria Farmaceutica Serono S.p.A., Guidonia Montecelio (RM), Italy |
| CRYSTAL STRUCTURE DETERMINATION FROM POWDER X-RAY DIFFRACTION DATA
|
Liesbeth Theunissen, Johnson and Johnson Pharmaceutical Research and Development, Beerse, Belgium |
Wednesday, 21 February
| Morning |
Formulation, Product Development, Drug Delivery and Polymorph and Salt Screening Session Chair: G. Stephenson, Eli Lilly & Company, Indianapolis, IN, USA |
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 9.00-10.00 |
Invited |
PRACTICAL IMPLICATIONS OF SOLID STATE ATTRIBUTES DURING DRUG DISCOVERY AND DEVELOPMENT
|
Srini Venkatesh, Bausch & Lomb, Rochester, NY, USA |
| 10.00-11.00 |
Invited |
USE OF X-RAY POWDER DIFFRACTOMETRY IN DRUG DISCOVERY, PREFORMULATION AND DRUG PRODUCT CHARACTERIZATION
|
Raj Suryanarayanan, University of Minnesota, Minneapolis, MN, USA |
| 11.00-11.30 |
Break |
|
|
| 11.30-12.00 |
Contributed |
X-RAY POWDER DIFFRACTION AT THE HEART OF PHYSICAL FORM DISCOVERY IN CPOSS
|
Alastair Florence, University of Strathclyde, Glasgow, UK |
| 12.00-12.30 |
Contributed |
TBD |
TBD |
| 12.30-13.00 |
Contributed |
HIGH RESOLUTION, HIGH THROUGHPUT X-RAY POWDER DIFFRACTION (HR HT XRPD) EXPERIMENTS AND DATA ANALYSIS
|
Detlef Beckers, PANalytical, Almelo, The Netherlands |
| 13.00-13.30 |
Contributed |
QUANTITATIVE ANALYSIS OF MIXTURES USING HIGH THROUGHPUT INSTRUMENTATION WITHOUT THE USE OF STANDARDS
|
Christopher Gilmore, University of Glasgow, Glasgow, Scotland, UK |
| 13.30-13.30- 15.00 |
Lunch |
|
|
| Afternoon |
Patent and Regulatory Issues
Chair: P.Varlashkin, GlaxoSmithKline, Durham, NC, USA |
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 15.00-16.00 |
Invited |
TRENDS IN SOLID FORM PATENTS: COCRYSTAL IP OPPORTUNITIES AND CHALLENGES |
Eyal Barash, Aptuit Consulting, West Lafayette, IN, USA |
| 16.00-16.30 |
Break |
|
|
| 16.30-17.00 |
|
An Invitation to Participate in an XRD Round Robin |
John Faber, International Centre for Diffraction Data, Newtown Square, Pennsylvania, USA |
Thursday, 22 February
| Morning |
New Frontiers for XRD in Pharmaceutical R&D Session Chair: J. Han, Novartis Institutes for Biomedical Research, Inc., Cambridge, MA, USA
|
| Time |
Type |
Title of Paper |
Speaker & Affiliation |
| 8.30-9.30 |
Invited |
CHARACTERIZATION OF INTACT PHARMACEUTICAL FILM-COATED TABLETS BY MICRODIFFRACTOMETRY
|
Hiroyuki Yamada, Mitsubishi Pharma Co., Kamisu, Ibaraki, Japan |
| 9.30-10.30 |
Invited |
THE ROLE OF PXRD IN QbD AND PAT
|
Shawn Yin, Bristol-Myers Squibb Co., New Brunswick, NJ, USA |
| 10.30-10.45 |
Break |
|
|
| 10.45-11.15 |
Contributed |
CHARACTERIZATION OF INSULIN MICROCRYSTALS IN PHARMACEUTICAL SUSPENSIONS
|
Mathias Norrman, Novo Nordisk, Bagsvaerd, Denmark |
| 11.15-11.45 |
Contributed |
GEOMETRY AND CONFIGURATION OF XRD SYSTEMS FOR PHARMACEUTICAL
|
Bob He, Bruker AXS, Madison, WI, USA |
| 11.45-12.15 |
Contributed |
NON-AMBIENT CONDITIONS X-RAY POWDER DIFFRACTION IN PHARMACEUTICAL INDUSTRY
|
Olaf Grassmann, F. Hoffmann-La Roche, Basel, Switzerland |
| 12.15 |
|
Q&A/Closing Remarks
|
|
Stay Informed
For the latest symposium information:
Visit www.icdd.com/ppxrd or Phone: +610-325-9814
Fax: +610-325-9823
E-mail: ppxrd@icdd.com
To receive a brochure, e-mail your mailing address to ppxrd@icdd.com
.
|
|
|